Webb24 dec. 2024 · With a market capitalization of US$1.2b, Sangamo Therapeutics is a decent size, so it is probably on the radar of institutional investors. In the chart below, we can see that institutions are ... Webb11 apr. 2024 · The recent price decline of 13% in Design Therapeutics, Inc.'s (NASDAQ:DSGN) stock may have disappointed insiders who bought US$182k worth of shares at an average price of US$8.10 in the past 12 months.Insiders invest with the hopes of seeing their money grow in value over time. However, as a result of recent losses, …
Vaibhavi Chokshi RAC - Associate Director, CMC Regulatory …
WebbMarket Cap. Sangamo Therapeutics market cap history and chart from 2010 to 2024. Market capitalization (or market value) is the most commonly used method of … WebbSangamo is using groundbreaking science and novel technology to replace today’s symptomatic treatments with tomorrow’s genomic cures. We are pursuing programs … how to stop using cilift
Sangamo Therapeutics, Inc. (NASDAQ:SGMO) Receives Average ...
Webb14 apr. 2024 · The stock has a market capitalization of $281.21 million, a PE ratio of -1.31 and a beta of 1.08. Sangamo Therapeutics has a 52 week low of $1.35 and a 52 week high of $6.42. Sangamo Therapeutics (NASDAQ:SGMO - Get Rating) last announced its earnings results on Wednesday, February 22nd Webb10 apr. 2024 · Sangamo Therapeutics Inc., whose market valuation is $281.40 million at the time of this writing, is expected to release its quarterly earnings report May 03, 2024 … WebbIn this position, played a lead role in the strategic development and globalisation of the Animal Health business, including entry into the US market. Qualifications are a first class honors degree in Veterinary Science from Melbourne University and an MBA from the Melbourne Business School. Specialties: Biotechnology, Pharmaceuticals Business … how to stop using crunchyroll beta